Coya Therapeutics, Inc. (COYA)
5.01
+0.12
(+2.45%)
USD |
NASDAQ |
Sep 21, 16:00
5.01
0.00 (0.00%)
After-Hours: 20:00
Coya Therapeutics Price : 5.01 for Sept. 21, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 4.76 | 5.085 | 4.705 | 4.89 | 403457.0 |
| Sep 17, 2026 | 4.54 | 4.89 | 4.54 | 4.76 | 221539.0 |
| Sep 16, 2026 | 4.66 | 4.719 | 4.46 | 4.46 | 129322.0 |
| Sep 15, 2026 | 4.62 | 4.72 | 4.49 | 4.65 | 215172.0 |
| Sep 14, 2026 | 4.39 | 4.78 | 4.33 | 4.64 | 201468.0 |
| Sep 11, 2026 | 4.59 | 4.66 | 4.37 | 4.38 | 139342.0 |
| Sep 10, 2026 | 4.61 | 4.62 | 4.455 | 4.52 | 93464.00 |
| Sep 09, 2026 | 4.55 | 4.695 | 4.53 | 4.61 | 77819.00 |
| Sep 08, 2026 | 4.82 | 4.82 | 4.595 | 4.61 | 98354.00 |
| Sep 04, 2026 | 4.54 | 4.77 | 4.52 | 4.76 | 75759.00 |
| Sep 03, 2026 | 4.50 | 4.58 | 4.36 | 4.55 | 100315.0 |
| Sep 02, 2026 | 4.53 | 4.648 | 4.39 | 4.42 | 61903.00 |
| Sep 01, 2026 | 4.52 | 4.630 | 4.48 | 4.51 | 101246.0 |
| Aug 31, 2026 | 4.58 | 4.698 | 4.51 | 4.56 | 47433.00 |
| Aug 28, 2026 | 4.82 | 4.82 | 4.55 | 4.59 | 153108.0 |
| Aug 27, 2026 | 5.14 | 5.14 | 4.76 | 4.86 | 77622.00 |
| Aug 26, 2026 | 5.02 | 5.030 | 4.83 | 4.87 | 54399.00 |
| Aug 25, 2026 | 4.99 | 5.22 | 4.98 | 5.04 | 145185.0 |
| Aug 24, 2026 | 4.89 | 5.26 | 4.71 | 4.96 | 147065.0 |
| Aug 21, 2026 | 4.90 | 4.95 | 4.805 | 4.87 | 70948.00 |
| Aug 20, 2026 | 5.00 | 5.00 | 4.73 | 4.86 | 59525.00 |
| Aug 19, 2026 | 4.96 | 5.10 | 4.95 | 4.97 | 118873.0 |
| Aug 18, 2026 | 4.65 | 4.93 | 4.65 | 4.92 | 106647.0 |
| Aug 17, 2026 | 4.81 | 4.81 | 4.63 | 4.67 | 67279.00 |
| Aug 14, 2026 | 4.70 | 4.85 | 4.55 | 4.79 | 113556.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 68.80 |
| Oncolytics Biotech, Inc. | 0.7679 |
| Sangamo Therapeutics, Inc. | 0.1449 |
| Sarepta Therapeutics, Inc. | 20.13 |
| Anixa Biosciences, Inc. | 2.70 |
Price Related Metrics
| PS Ratio | 13.08 |
| Price to Book Value | 2.716 |
| Earnings Yield | -19.97% |
| Market Cap | 117.52M |